Results 51 to 60 of about 4,628,908 (247)
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Identification of a novel luminal molecular subtype of breast cancer.
The molecular classification of human breast tumors has afforded insights into subtype specific biological processes, patient prognosis and response to therapies.
Anna Dvorkin-Gheva (201099) +5 more
core +1 more source
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
Molecular pathways and associated proteins in PMS subtype.
Molecular pathways and associated proteins in PMS subtype were shown. Individual protein list of each PMS patients were processed and compared with control samples regarding their fold changes.
O. Uğur Sezerman (735106) +8 more
core +1 more source
Melanoma Molecular Subtypes: Unifying and Paradoxical Results [PDF]
In this issue, Hacker and colleagues provide further evidence that molecular subtypes of malignant melanoma may develop along divergent pathways. The authors did not find an association between somatic BRAF-mutant melanoma and germline melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in light of previous studies demonstrating
Thomas, Nancy E. +4 more
openaire +2 more sources
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Molecular subtypes of muscle-invasive bladder tumors have emerged as a promising research tool with potential to stratify patients for neoadjuvant treatment.
Liedberg, Fredrik, +18 more
core +1 more source
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease. Seven subtypes have been described based on gene expression patterns. Herein, we characterized the tumor biology and clinical behavior of the immunomodulatory (IM) subtype ...
Rubén Rodríguez-Bautista +17 more
core +1 more source
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
NGS meta-analysis: first 15 most frequently mutated genes in each molecular subtype.
Gene mutation associated with the corresponding molecular subtype.
Nadine Carbuccia (508059) +18 more
core +1 more source

